Biosimilars· May 13, 2026 · 4 min read
How to read FDA biosimilar interchangeability without over-reading it
Interchangeability is a real FDA designation, but it is not a commercial launch plan. Here is what the Purple Book status does, what state substitution controls, and...
By Ran Chen#Biosimilars#Interchangeability#FDA Approval
